Document Detail

Device-based therapies for resistant hypertension.
MedLine Citation:
PMID:  23173589     Owner:  NLM     Status:  Publisher    
Hypertension is universally considered the most detrimental among cardiovascular risk factors. Despite the overwhelming evidence of benefits deriving from lowering blood pressure, its control among the hypertensive population is still unsatisfactory. Resistant hypertension has a non negligible prevalence among hypertensive patients, and it is associated with a worse cardiovascular prognosis. There is need of new therapeutic approaches for reducing cardiovascular risk in this population. Sympathetic nervous system is known to play a major role in development and maintenance of essential hypertension, thus in the past decades several efforts have been made to counteract its overactivation. Novel non-pharmacological, promising approaches targeting sympathetic nervous system are now available, such as renal denervation and baroceptor-activating therapy. This review is aimed at describing essential clinical aspects of resistant hypertension, physiopatological basis of autonomic modulation as a target for hypertension treatment, and the available clinical evidence about efficacy and safety of device-based therapies for resistant hypertension. Present limitations and future perspectives were also considered.
Rosa Maria Bruno; Alessia Di Giulio; Giampaolo Bernini; Agostino Virdis; Lorenzo Ghiadoni; Stefano Taddei
Related Documents :
2883209 - Analysis of mechanisms responsible for the bradycardic action of naloxone after haemorr...
22923629 - Prevalence, awareness, treatment and control of hypertension in a self-selected sub-sah...
23535989 - Higher leptin is associated with hypertension: the multi-ethnic study of atherosclerosis.
24245839 - Neighborhood problems and nocturnal blood pressure dipping.
22990869 - End-tidal carbon dioxide is better than arterial pressure for predicting volume respons...
2897199 - Nephrectomy-induced alterations in the synthesis of catecholamines in the sympathetic n...
3946259 - Continuous-wave doppler in children with ventricular septal defect: noninvasive estimat...
10627659 - Comparative acute toxicity of o-chlorobenzylidene malononitrile (cs) and oleoresin caps...
9568349 - Arterial and venous plasma catecholamines during submaximal steady-state exercise.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-11-19
Journal Detail:
Title:  Current pharmaceutical design     Volume:  -     ISSN:  1873-4286     ISO Abbreviation:  Curr. Pharm. Des.     Publication Date:  2012 Nov 
Date Detail:
Created Date:  2012-11-23     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9602487     Medline TA:  Curr Pharm Des     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Department of Internal Medicine, University of Pisa, Via Roma 67, 56126 Pisa, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Functional and structural alterations of large arteries: methodological issues.
Next Document:  Sleep Loss and Hypertension: a systematic review.